Adrenal enzyme impairment in neonates and adolescents treated with ritonavir and protease inhibitors for HIV exposure or infection.

Kariyawasam, D; Simon, A; Laborde, K; Parat, S; Souchon, P-F; Frange, P; Blanche, S; Polak, M

Kariyawasam, D; Simon, A; Laborde, K; Parat, S; Souchon, P-F; Frange, P; Blanche, S; Polak, M.

Affiliation

Kariyawasam D; Pediatric Endocrinology Gynecology and Diabetology Unit, Assistance Publique-Hôpitaux de Paris (AP-HP) and IMAGINE Institute affiliate, Paris, France.

Horm Res Paediatr ; 81(4): 226-31, 2014.

Article in En | MEDLINE | ID: mdl-24577112

Subject(s)

Adrenal Glands/drug effects; Anti-HIV Agents/pharmacology; HIV Infections/drug therapy; Protease Inhibitors/pharmacology; Ritonavir/pharmacology; 17-alpha-Hydroxypregnenolone/blood; 17-alpha-Hydroxyprogesterone/blood; Adolescent; Adrenal Glands/physiopathology; Anti-HIV Agents/therapeutic use; Dehydroepiandrosterone/blood; Dehydroepiandrosterone Sulfate/blood; Female; HIV Infections/blood; HIV Infections/physiopathology; Humans; Hydrocortisone/blood; Infant, Newborn; Male; Protease Inhibitors/therapeutic use; Ritonavir/therapeutic use; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protease Inhibitors / HIV Infections / Adrenal Glands / Ritonavir / Anti-HIV Agents Limits: Adolescent / Adult / Female / Humans / Male / Newborn Language: En Journal: Horm Res Paediatr Year: 2014 Document type: Article

Fulltext

XML

PubMed Links

Search on Google